Verbeke H, Van Hecke D, Bauraing C, Dierick A, Colleye O, Dalle I
Appl Immunohistochem Mol Morphol. 2023; 32(1):1-16.
PMID: 38054253
PMC: 10695338.
DOI: 10.1097/PAI.0000000000001165.
Abdelkareem A, Iews M, Ait-Allah A, Rasheed S, Helmy Y, Habte R
Reprod Sci. 2023; 30(10):3084-3091.
PMID: 37126206
DOI: 10.1007/s43032-023-01243-7.
Laberiano-Fernandez C, Hernandez-Ruiz S, Rojas F, Parra E
Front Mol Biosci. 2021; 8:660202.
PMID: 34532339
PMC: 8438151.
DOI: 10.3389/fmolb.2021.660202.
Sun W, Zhou J, Zhou J
Zhongguo Fei Ai Za Zhi. 2021; 24(1):36-42.
PMID: 33478189
PMC: 7849039.
DOI: 10.3779/j.issn.1009-3419.2020.102.47.
Xu B, Alminawi S, Boulianne P, Shang Y, Downes M, Slodkowska E
Virchows Arch. 2020; 478(5):985-993.
PMID: 33175216
DOI: 10.1007/s00428-020-02960-z.
Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
Wu M, Sun Y, Wu J, Liu G
Med Sci Monit. 2020; 26:e922107.
PMID: 32180586
PMC: 7101203.
DOI: 10.12659/MSM.922107.
Multiplex immunohistochemistry/immunofluorescence is superior to tumor mutational burden and PD-L1 immunohistochemistry for predicting response to anti-PD-1/PD-L1 immunotherapy.
Hu W
Thorac Cancer. 2019; 11(1):3-5.
PMID: 31722117
PMC: 6938747.
DOI: 10.1111/1759-7714.13233.
Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP).
Cheung C, Barnes P, Bigras G, Boerner S, Butany J, Calabrese F
Appl Immunohistochem Mol Morphol. 2019; 27(10):699-714.
PMID: 31584451
PMC: 6887625.
DOI: 10.1097/PAI.0000000000000800.
The association between MAD2 and prognosis in cancer: a systematic review and meta-analyses.
Byrne T, Coleman H, Cooper J, McCluggage W, McCann A, Furlong F
Oncotarget. 2017; 8(60):102223-102234.
PMID: 29254238
PMC: 5731948.
DOI: 10.18632/oncotarget.18414.
Cytoplasmic expression of C-MYC protein is associated with risk stratification of mantle cell lymphoma.
Gong Y, Zhang X, Chen R, Wei Y, Zou Z, Chen X
PeerJ. 2017; 5:e3457.
PMID: 28626618
PMC: 5472035.
DOI: 10.7717/peerj.3457.
Variability in Platelet-Derived Growth Factor Receptor Alpha Antibody Specificity May Impact Clinical Utility of Immunohistochemistry Assays.
Holzer T, Reising L, Credille K, Schade A, Oakley G
J Histochem Cytochem. 2016; 64(12):785-810.
PMID: 27837159
PMC: 5131747.
DOI: 10.1369/0022155416673979.
BRCA1 and MDM2 as independent blood-based biomarkers of head and neck cancer.
Bhowmik A, Das S, Bhattacharjee A, Choudhury B, Naiding M, Ghosh S
Tumour Biol. 2016; 37:15729–15742.
PMID: 27714671
DOI: 10.1007/s13277-016-5359-5.
Levey-Jennings Analysis Uncovers Unsuspected Causes of Immunohistochemistry Stain Variability.
Vani K, Sompuram S, Naber S, Goldsmith J, Fulton R, Bogen S
Appl Immunohistochem Mol Morphol. 2015; 24(10):688-694.
PMID: 26469328
PMC: 4833720.
DOI: 10.1097/PAI.0000000000000260.
Proficiency testing in immunohistochemistry--experiences from Nordic Immunohistochemical Quality Control (NordiQC).
Vyberg M, Nielsen S
Virchows Arch. 2015; 468(1):19-29.
PMID: 26306713
PMC: 4751198.
DOI: 10.1007/s00428-015-1829-1.
Modeling Canadian Quality Control Test Program for Steroid Hormone Receptors in Breast Cancer: Diagnostic Accuracy Study.
Perez T, Makrestsov N, Garatt J, Torlakovic E, Gilks C, Mallett S
Appl Immunohistochem Mol Morphol. 2015; 24(10):679-687.
PMID: 26200834
PMC: 5106078.
DOI: 10.1097/PAI.0000000000000249.
Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review.
Fedchenko N, Reifenrath J
Diagn Pathol. 2014; 9:221.
PMID: 25432701
PMC: 4260254.
DOI: 10.1186/s13000-014-0221-9.
Banff Initiative for Quality Assurance in Transplantation (BIFQUIT): reproducibility of polyomavirus immunohistochemistry in kidney allografts.
Adam B, Randhawa P, Chan S, Zeng G, Regele H, Kushner Y
Am J Transplant. 2014; 14(9):2137-47.
PMID: 25091177
PMC: 4194133.
DOI: 10.1111/ajt.12794.
Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panel.
Torlakovic E, Francis G, Garratt J, Gilks B, Hyjek E, Ibrahim M
Appl Immunohistochem Mol Morphol. 2014; 22(4):241-52.
PMID: 24714041
PMC: 4206554.
DOI: 10.1097/PAI.0000000000000069.
Antigen retrieval immunohistochemistry: review and future prospects in research and diagnosis over two decades.
Shi S, Shi Y, Taylor C
J Histochem Cytochem. 2011; 59(1):13-32.
PMID: 21339172
PMC: 3201121.
DOI: 10.1369/jhc.2010.957191.